Full name
MEDERE LABORATOIRES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
10.89.Z - Production of other food products, not elsewhere classified
10.86.Z - Production of homogenized food products and diet food
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.4 - Wholesale trade of household goods
46.46 - Wholesale trade of pharmaceutical and medical products
46.75 - Wholesale trade
47 - Retail trade
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0,1 | -0,1 | -168,7 |
EBITDA | -0 | |||
Short time liabilities | 0,4 | |||
Income tax | 0 | 0 | 54 | |
Equity capital | 0,8 | 0,9 | 0,8 | -8,8 |
Operating profit (EBIT) | -0,1 | |||
Assets | 1 | 1,3 | 1,2 | -8,6 |
Net profit (loss) | 0 | 0,1 | -0,1 | -181,5 |
Cash | 0 | |||
Net income from sale | 0,7 | |||
Liabilities and provisions for liabilities | 0,3 | 0,5 | 0,4 | -8,3 |
Working assets | 0,5 | 0,7 | 0,6 | -15,4 |
Depreciation | 0 | |||
Basic operational activity income | 0,5 | 0,7 | 42,1 | |
% | % | % | p.p. | |
Profitability of capital | 2,5 | 10,8 | -9,6 | -20,4 |
Equity capital to total assets | 74,9 | 66,1 | 66 | -0,1 |
Gross profit margin | 5,5 | 14,7 | -11,5 | -26,2 |
EBITDA Margin | -6,3 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 196 | |||
Current financial liquidity indicator | 1.8064152002334595 | |||
Net dept to EBITDA | -5.805927753448486 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane